Status:

TERMINATED

Cold Laser: A Modality to Promote Vulvar Healing and Pain Relief

Lead Sponsor:

ProHealth Care, Inc

Conditions:

Vulvar Vestibulitis

Vestibulodynia

Eligibility:

FEMALE

18+ years

Phase:

NA

Brief Summary

The objectives of this pilot study are to demonstrate effectiveness of application of the Erchonia Laser (manufactured by Erchonia Corporation),a non-invasive, non-significant risk low level laser red...

Detailed Description

In the current proposed pilot study, application of a low level laser light device, manufactured by Erchonia Corporation, to reduce the pain of vulvar vestibulitis will be evaluated. The Erchonia Lase...

Eligibility Criteria

Inclusion

  • • Female
  • 18 years or older
  • Current diagnosis of provoked or non-provoked vulvar vestibulitis made by a suitably qualified medical professional
  • Vulvar pain is chronic, defined as having been present for at least 3 months.
  • Visual Analog Score for typical vulvar pain is at least 30/100 Patient has been stabilized on all hormonal interventions (i.e., birth control pills, topical or oral estrogen agents) and will not be altered for the course of the treatment protocol of this study.
  • Subject is willing and able to decrease use of current pain relief medication to manage vulvar pain throughout study participation, and is willing and able to refrain from engaging in other non-study treatments to manage her vulvar vestibulitis symptoms

Exclusion

  • • Vulvar dermatoses such as lichen sclerosis, squamous cell hyperplasia, or lichen planus
  • Active vaginal or pelvic infection, herpetic infections, vulvar cancer and/or treatment for cancer
  • Previous vestibulectomy or other surgical or procedural interventions (for vestibulitis ) to the treatment area
  • Active infection, wound or other external trauma to the areas to be treated with the laser
  • Other neurological disorders such as Multiple Sclerosis
  • Photosensitivity disorder
  • Pregnant or planning pregnancy prior to study end
  • Serious mental health illness, developmental disability or cognitive impairment that may preclude adequate comprehension of the consent form or ability to record study measures

Key Trial Info

Start Date :

March 1 2014

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

July 1 2015

Estimated Enrollment :

10 Patients enrolled

Trial Details

Trial ID

NCT02204319

Start Date

March 1 2014

End Date

July 1 2015

Last Update

July 2 2017

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.